Standout Papers

A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis 2023 2026 202467
  1. A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis (2023)
    Jay Tuttle, Edit Drescher et al. New England Journal of Medicine

Immediate Impact

4 from Science/Nature 61 standout
Sub-graph 1 of 20

Citing Papers

Therapeutic advances in rheumatoid arthritis
2024 Standout
The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout

Works of Jay Tuttle being referenced

A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
2023 Standout

Author Peers

Author Last Decade Papers Cites
Jay Tuttle 370 259 329 38 1.1k
Valerio Pittoni 124 107 346 30 1.2k
Nabil Mtiraoui 214 140 233 49 1.1k
H Imura 375 93 241 42 1.2k
Tünde Tarr 111 126 553 58 1.3k
Rachel T. McGrath 164 96 153 34 969
Marjorie Poggi 97 476 411 29 1.2k
Asuka Sakata 182 134 153 35 887
Claire Perret 228 192 192 31 1.2k
Antonio Pecoraro 143 99 653 37 1.1k
Paula Buendía 174 69 367 24 1.3k

All Works

Loading papers...

Rankless by CCL
2026